157 related articles for article (PubMed ID: 34422028)
1. Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPAR
Zhou Y; Yin T; Shi M; Chen M; Wu X; Wang K; Cheang I; Li Y; Shang H; Zhang H; Li X
PPAR Res; 2021; 2021():9947656. PubMed ID: 34422028
[TBL] [Abstract][Full Text] [Related]
2.
Ni G; Wang K; Zhou Y; Wu X; Wang J; Shang H; Wang L; Li X
Ann Transl Med; 2020 Sep; 8(17):1064. PubMed ID: 33145283
[TBL] [Abstract][Full Text] [Related]
3.
Cheng H; Wu X; Ni G; Wang S; Peng W; Zhang H; Gao J; Li X
Ann Transl Med; 2020 Nov; 8(21):1396. PubMed ID: 33313141
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α.
Gao RR; Wu XD; Jiang HM; Zhu YJ; Zhou YL; Zhang HF; Yao WM; Li YQ; Li XL
Ann Transl Med; 2018 Apr; 6(8):153. PubMed ID: 29862242
[TBL] [Abstract][Full Text] [Related]
5. Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/PPARγ pathway in estrogen-deficient mice.
Song LL; Zhang Y; Zhang XR; Song YN; Dai HZ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5477-5486. PubMed ID: 31298401
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ.
Wu X; Zhang T; Lyu P; Chen M; Ni G; Cheng H; Xu G; Li X; Wang L; Shang H
Front Cardiovasc Med; 2021; 8():698056. PubMed ID: 34336956
[No Abstract] [Full Text] [Related]
7. Citri Reticulatae Pericarpium alleviates postmyocardial infarction heart failure by upregulating PPARγ expression.
Chen M; Zhu H; Zhu Q; Wu X; Zhou Y; Gao R; Shi M; Zhang T; Yin T; Zhang H; Shang H; Li X
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):661-673. PubMed ID: 35278230
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.
Shen S; Jiang H; Bei Y; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Wei C; Shang H; Li X
Cell Physiol Biochem; 2017; 42(3):876-888. PubMed ID: 28647730
[TBL] [Abstract][Full Text] [Related]
9. LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice.
Zhang X; Zhao D; Feng J; Yang X; Lan Z; Yang T; Kong X; Qu H; Zhou H
Evid Based Complement Alternat Med; 2021; 2021():5518083. PubMed ID: 34257682
[TBL] [Abstract][Full Text] [Related]
10. Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
Shen ZX; Yang QZ; Li C; Du LJ; Sun XN; Liu Y; Sun JY; Gu HH; Sun YM; Wang J; Duan SZ
Atherosclerosis; 2018 Jul; 274():199-205. PubMed ID: 29800789
[TBL] [Abstract][Full Text] [Related]
11. Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis.
Li Y; He Q; He CY; Cai C; Chen Z; Duan JZ
ESC Heart Fail; 2023 Aug; 10(4):2510-2523. PubMed ID: 37290760
[TBL] [Abstract][Full Text] [Related]
12. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.
Singla DK; Lyons GE; Kamp TJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1308-14. PubMed ID: 17416601
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
[TBL] [Abstract][Full Text] [Related]
14. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
18. Yixin-Fumai granules improve sick sinus syndrome in aging mice through Nrf-2/HO-1 pathway: A new target for sick sinus syndrome.
Zhang H; Li L; Hao M; Chen K; Lu Y; Qi J; Chen W; Ren L; Cai X; Chen C; Liu Z; Zhao B; Li Z; Hou P
J Ethnopharmacol; 2021 Sep; 277():114254. PubMed ID: 34062246
[TBL] [Abstract][Full Text] [Related]
19. Exercise attenuates angiotensinⅡ-induced muscle atrophy by targeting PPARγ/miR-29b.
Liu Q; Chen L; Liang X; Cao Y; Zhu X; Wang S; Li J; Gao J; Xiao J
J Sport Health Sci; 2022 Nov; 11(6):696-707. PubMed ID: 34116237
[TBL] [Abstract][Full Text] [Related]
20. PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.
Yeligar SM; Kang BY; Bijli KM; Kleinhenz JM; Murphy TC; Torres G; San Martin A; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2018 May; 58(5):648-657. PubMed ID: 29182484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
